Statins don't pose threat to your memory

Image
ANI Washington
Last Updated : Jun 09 2015 | 10:42 AM IST

If you are taking statins, there's no need to worry as a new study has suggested that the cholesterol-lowering drugs most likely do not cause short-term memory loss.

Lead study author Brian L. Strom of Rutgers University said that limited previous studies and some statin-drug takers have anecdotally reported memory lapses after taking popular lipid-lowering drugs (LLDs) called statins. The result has been that some people have stopped taking their statins, inappropriately.

The study compared new users of statins with people not taking statins. New statin users also were compared to a second control group - patients taking nonstatin LLDs, which had not been done before.

More patients taking statins indeed reported memory loss in the 30-day period after first taking the drugs, compared to non-users, the study found. The same, however, was found with the nonstatin LLDs.

Either it means that anything that lowers cholesterol has the same effect on short-term memory, which is not scientifically credible because you're dealing with drugs with completely different structures, Strom noted, adding that detection bias is more likely the reason, meaning patients taking a new drug visit their doctors more frequently and are highly attuned to their health.

Strom added that when patients are put on statins or any new drug, they're seen more often by their doctor or they themselves are paying attention to whether anything is wrong. So if they have a memory problem, they're going to notice it.

He continued that even if it has nothing to do with the drug, they're going to blame it on the drug.

Strom concluded that people who have high cholesterol should be on statins, which include atorvastatin, cerivastatin, fluvastatin, pravastatin and simvastatin, while nonstatin LLDs include cholestyramine, colestipol hydrochloride, colesevelam, clofibrate and gemfibrozil, are a very effective therapy, which is very safe.

The study appears in The Journal of the American Medical Association-Internal Medicine.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 09 2015 | 10:32 AM IST

Next Story